Prognostic relevance of protein expression, clinical factors, and MYD88 mutation in primary bone lymphoma.

about

Prognostic relevance of protein expression, clinical factors, and MYD88 mutation in primary bone lymphoma.

Item

http://www.wikidata.org/entity/Q42371562

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@en

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@nl

type

Item

label

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@en

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@nl

prefLabel

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@en

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@nl

P1476

Prognostic relevance of protei ...... tion in primary bone lymphoma.

@en

P2093

Bing Chen

http://www.w3.org/2001/XMLSchema#string

Cuiling Zhang

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jian Ouyang

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Jingyan Xu

http://www.w3.org/2001/XMLSchema#string

Juan Li

http://www.w3.org/2001/XMLSchema#string

Min Zhou

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Qiguo Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

JAK/STAT signaling in hematological malignancies.

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.

Clinical characteristics and outcomes of primary bone lymphoma in Korea

Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas

Malignant lymphoma of bone: a review of 119 patients.

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

Primary and secondary bone lymphomas.

P304

65609-65619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19936

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029457

http://www.w3.org/2001/XMLSchema#string

P932

5630357

http://www.w3.org/2001/XMLSchema#string